BioNano Genomics, Inc. (BNGO)

NASDAQ: BNGO · IEX Real-Time Price · USD
1.99
-0.10 (-5.02%)
Dec 5, 2022 3:45 PM EST - Market open
-5.02%
Market Cap 620.57M
Revenue (ttm) 25.89M
Net Income (ttm) -116.87M
Shares Out 289.70M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,381,891
Open 2.16
Previous Close 2.09
Day's Range 1.98 - 2.17
52-Week Range 1.16 - 4.35
Beta 2.26
Analysts Buy
Price Target 8.84 (+343.1%)
Earnings Date Nov 3, 2022

About BNGO

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Sap... [Read more]

Industry Life Sciences Tools & Services
IPO Date Aug 21, 2018
CEO R. Erik Holmlin
Employees 299
Stock Exchange NASDAQ
Ticker Symbol BNGO
Full Company Profile

Financial Performance

In 2021, BNGO's revenue was $17.98 million, an increase of 111.47% compared to the previous year's $8.50 million. Losses were -$72.44 million, 76.2% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for BNGO stock is "Buy." The 12-month stock price forecast is 8.84, which is an increase of 343.11% from the latest price.

Price Target
$8.84
(343.11% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Bears are Losing Control Over Bionano Genomics, Inc. (BNGO), Here's Why It's a 'Buy' Now

Bionano Genomics, Inc. (BNGO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions cou...

4 days ago - Zacks Investment Research

Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical...

SAN DIEGO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that it has entered into a definitive agreement to acquire Purigen Biosystems, Inc. (Purigen), a compan...

6 days ago - GlobeNewsWire

3 Penny Stocks You Can Count On in This Uncertain Market

Many people have trouble deciding where to invest their money. There are so many options, but it can be difficult to decide which one of them is the best.

Other symbols: EGYGPRO
1 week ago - InvestorPlace

Publication Shows Utility of OGM in Solid Tumor Research with Study on Detection of Complex Genomic Rearrangements in...

SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study utilizing optical genome mapping (OGM) to detect structural variants (SVs) a...

2 weeks ago - GlobeNewsWire

Bionano Genomics Appoints Donna Polizio as Its First Ever Global Head of Market Access

SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has appointed Donna Polizio as its global head of market access, further strengthening its lead...

3 weeks ago - GlobeNewsWire

2 Penny Stocks That Could Make You Filthy Rich

These low-priced equities could explode higher soon.

Other symbols: TLRY
3 weeks ago - The Motley Fool

3 Hypergrowth Stocks That Will Make You a Millionaire by 2027

During the current earnings season, a few of the companies whose stocks I own delivered great third-quarter results. These results, along with their other achievements, shows that the firms' technologie...

Other symbols: JKSSDGR
1 month ago - InvestorPlace

7 Cheap Penny Stocks to Buy Before They Pop Off

It may seem a little crazy to talk about finding cheap penny stocks to buy at this time. The economy is cooling, and even blue-chip stocks are struggling to gain traction.

Other symbols: AMRSCGCFCELHOFVMMATBTG
1 month ago - InvestorPlace

Bionano Genomics, Inc. (BNGO) Reports Q3 Loss, Tops Revenue Estimates

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 8.33% and 7.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business Progress

–  55% year-over-year revenue growth in Q3 2022

1 month ago - GlobeNewsWire

3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall Street

Select analysts and pundits foresee game-changing upside from this fast-paced trio.

Other symbols: OCGNTSLA
1 month ago - The Motley Fool

Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest

It's true that the troika of Microsoft (NASDAQ: MSFT ), Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ), and Meta (NASDAQ: META ), much loved by the Street for the decade that ended in mid-2021, reported disap...

Other symbols: ENPHESLTILMNNOWONSWAV
1 month ago - InvestorPlace

Bionano Genomics Announces Extensive Lineup of Content at Association for Molecular Pathology (AMP) Annual Meeting Fe...

SAN DIEGO, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the Association for Molecular Pathology (AMP) Annual Meeting and Expo 2022 with a ...

1 month ago - GlobeNewsWire

Bionano Genomics to Report Third Quarter 2022 Financial Results and Host a Conference Call and Webcast on November 3,...

SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, November 3, 2022 at 4:30 p.m. Eastern Time to...

1 month ago - GlobeNewsWire

Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy?

Bionano's stock price movements have little to do with its successes.

1 month ago - The Motley Fool

What Is Going on With Bionano Genomics (BNGO) Stock Today?

Bionano Genomics (NASDAQ: BNGO ) stock is rising higher on Wednesday after providing an update on its Long String VANTAGE product. This is a system that handles “automated, high throughput isolation of ...

1 month ago - InvestorPlace

Hamilton and Bionano Genomics Announce Commercial Availability of World's First Ultra High Molecular Weight DNA Extra...

SAN DIEGO and RENO, Nev., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the Long String VANTAGE, a system for automated, high throughput isola...

1 month ago - GlobeNewsWire

Why Bionano Genomics' Shares Spiked 16.42% on Tuesday

On an up day for Wall Street, the genome-mapping company may have benefited from a short squeeze.

1 month ago - The Motley Fool

OGM Evaluated as a Method for Investigating Abnormal NIPT Results due to its Ability to Detect Chromosomal Structural...

SAN DIEGO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a peer-reviewed study evaluating optical genome mapping (OGM) as a method for invest...

1 month ago - GlobeNewsWire

Why Is Bionano Genomics (BNGO) Stock Up 11% Today?

Source: Dennis Diatel / Shutterstock.com Bionano Genomics (NASDAQ: BNGO ) stock is rising higher on Wednesday following the publication of a study related to optical genome mapping (OGM). According to t...

2 months ago - InvestorPlace

Bionano Genomics Announces Publication of Study from Sorbonne Université Showing that WGS Identified only 63% of Stru...

SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study showing the use of optical genome mapping (OGM) to investigate a molecular s...

2 months ago - GlobeNewsWire

Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with ...

SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano's optical genome mapping ...

2 months ago - GlobeNewsWire

7 Penny Stocks to Buy Now for Extraordinary Gains

If your initial instinct is that penny stocks represent extraordinarily risky ideas that feature little chance for success, you would be 100% correct. Clearly, conservative or risk-averse investors will...

Other symbols: AIRIDNNGTEVZLA
2 months ago - InvestorPlace

Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced Chromosomal Rearrangements Found ...

SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study utilizing OGM to detect cryptic balanced chromosomal rearrangements (BCRs) ...

2 months ago - GlobeNewsWire

Bionano Genomics Announces Publication of Study in MDS and AML Showing Utility for Refined Diagnostics and Prognostic...

SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study evaluating the performance of OGM for detection of cytogenetic abnormalitie...

2 months ago - GlobeNewsWire